Latest filing published 17 Mar 2022 for Parallax Health Sciences, INC., €589k.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Edward W. Withrow III: trading record in brief
All filings by Edward W. Withrow III on record concern Parallax Health Sciences, Inc., in the capacity of chief executive. We count 4 filings; the first trade dates from 7 January 2014 and the latest from 14 January 2022.
The open-market record is one-sided, with 1 purchase worth €2,675 and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
Most recently, on 17 March 2022, the filings show a transaction worth €589k in Parallax Health Sciences, Inc. The latest purchase dates back some time: it was published 4,688 days ago, on 7 January 2014. The median gap between a trade and its publication by SEC (Form 4) is 31 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Edward W. Withrow III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,491,053 shares@ US$0.0554.5% of flowCOMMON STOCKSEC:0001388410-22-000004:1
- 7,050,773 shares@ US$0.08100.0% of flowCOMMON STOCKSEC:0001388410-22-000004:0
- 36,462,819 sharesCOMMON STOCKSEC:0001388410-14-000003:0Canonical exit: 7 Apr 2014 (T+90)
- 36,462,819 shares0COMMON STOCKSEC:0001388410-14-000003:1
4 of 4 declarations